Abstracts Vol. 1 [International Conference on AIDS (11th: 1996: Vancouver, Canada)]

TuC 265(,VWe.B.32I, We.B 3286
lymphoma, Hodgkin's
No.0 1265, I h A.40/9,Th..4 141,
Ph 8.4224, S.C.433
lymphoma, non-Hodgkin's
Mc 0.1255, M B1292,NMoP3I1309,
No.0.310, M.B.431, T16A.40/6,
Ph 1.4078,31.A.40/9, LhB 184,
IL584141,1T.842 24,.T[.B.4225,
T6 8.4227, 3.8 422 8, T6.8.4229,
P..4232. 1..4233,68..4236,
16.8 4256, I lcD 5 144, T.B.2264,
ToY.43i, 7v..A.403, W178 3317,
We C.3430
macaques
Mc.A. 34, 1P6A.2 75, WeA 284,
We.A.3008
macrophages
Mo.AIOO, MA.1056,N oAIIO10,
h36841/9,36.86.4284, 1.A.2010,
To 1.201 3, We.A. I1OP, W.A. 141,
We.A.282, We A 302 3, v'ce.A.30/<,
We.A.3091, We.8 3181, We.8.327/
We..330 I
magnetic resonance imaging (MRI)
MNo.08.1264, M o.8B.268, NMco..3 I15,
TO..83,P60B4228,1o8.B2235
malaria
T.B04l 3,128..3 14, We.8.3200
malnutrition
No.8. 139/, MN'iB.42I, N iC.I59S,
168B4238,68.B4213,168B4245,
11.8 4246,4..4249, FL 84251,
Ph. B.4271I, Tu. B.2246, Tuo B.2249,
To. B 2 3 66,3Tu. B.2 38 I, lo. B.2 384,
We. 8. 83, 7We.OB 370)
mandatory testing, SEE testing,
mandatory
Pob C,.1151, Po.C.202, Wc.P3 3665,
We D.493
markers, surrogate
M.O 1 124, Mo..1 146, M 8.345,
No.8.1 349, MN.8 iO5, N O.. 354,
MNo.6B.29(3, MNo.C.129, P0o6.A 996,
PoL A. 1026,. PoL 8 067. 1.1.40 3.
T6A.03.P81 8 1448,
T.834247,' 11 84248 16.8.429,
16.14296,168.B4298. Ph O.4330,
16.1.4336, Ph C 125, 1 L C.222,3o 8.224.
lo.L.2343, hu.8 7i49 7823/1
To 8.237,T.8522, P.c.2538,
We.B3I124,.WeB.3 127, WeOB3 34,
We.8.I 38 We 8.33 3, We.i8O,
We.O 3381 We.B. I1 0, We.O.413,
We.C.3462, We.C 346/,We. 354/
maternal antibodies
Mo.C 1458, Pi.C.) 588. To (.2591
maternal-infant transmission, SEE
vertical transmission
Mo.1312,N O..434, Po6.C 129,
Pob..269, Pob.P3 1393, Ph 0.4324.
Th.C.4 I0, IciC.34, 0cC 344, Jo D482,
We.A.313, WeO.195, We.7.3438
matrix protein
T h.A.38 3, I cA.2034, Tc.A.2099
measles
Mio..304, We.B. 10

Nc.D1862,Nco.D. 1941 7..2 11,
P1 7.4397, T6.C 4624,16 P3364,

16 D.446, I D.24 (lii D.473, We.C.3564,
We.C.44 I
media
N.D1813 Mo.D.1814, Mo.D.1820,
MoDP. I182 1, Mo. D. I1824, Mo.D. I826,
Mc..I827, NoD I1828, Mo.D. I830,
Mci 131832, Mo.D. (833, Mo.D. 1834,
Mo P3 I1835, Mo.D. 183/, Mo.D. 1840,
No. D. 1920. Nc.D. 192 1, No.D. 1922,
Mo.P3 1923, Mo.D. 1924, Mo.D. 1928,
MolD. 1930, Mo.D. 1931, MoD. 1932,
NoP3 1 333, Mo.D.1936, Mo.D244,
No.7 247, No.D.250, Mo.D.25 1,
Ni.D.252, No.D.253, MoD.255,
No.D.256, No.13.475, Pub.C. I1I08,
Pob.D I112(3 PoO.C. 116 1, Pub.C. 11I89,
Pob.C I1206, Pob.C. I1247, Pub.C. 1265,
Pu.D. 1312, PoO.D. 1327, Pub.D. 1376,
P'ob.D I1386c, PoOP). 138/, PoO.D. 1390,
Pob P3. 139, Pob.P3 1392, Pob. D. 1393,
hob.. 1394, Piib.D. 1 395, PoO.D.1I436,
16.7.2 12,1 h.C.4397, T6.7.4426,
Th.c7.4435. Th..448 I 16h.7.4507,
16.7.451I8 16.7.4539,16.7.4544,
fT.C.4657 16h.7.4700,16h.7.4718,
16.D.4870, Th.D.49 /9, lo.C.2596,
3cc. D.246, Tu. D.2862, Tcc D.2872,
Tc.D.2873, Tc.D.2884, Tu.D.2885,
Tc.D.2889, lui.D.2899, PoD.29 I16,
3o.D.2925,Tu.D.2939, We.7.201,
We.C.3482, We.7.3565, We.D 132,
We.D.3/49, We.D.3755, We.D.3/7 I
medical records
No.7.IS57, No.D. 1889, Mo.D. 1927,
Pccb. D.I4603,VWe 7.3425
medical students
PobC. 1184, Pub.C.1215, Pcb.C.I/3I,
PoO.D. 1366,1 6.7 455 1,16.7.4560,
PT.D.4948, To.D.281I4, We.D.3639
megestrol
Tu.B.2247,We.B. I184
melanin
Ph.0 4206
membrane protein inhibitors
Tc.A.2040 3 i.8.2321I
meningitis
No.0. 136 3,16.0.4262, Po.B 21 95,
Tci.2 357, We B 3285, We.B.3363
meningoencephalitis, SEE also specific
pathogens
TL 0.4206
mental health
N.8.304. N.D. I1/7I3, N iD. 1794,
No.D. 188 7, Pub.1073, Pcib.7. 1 167,
Pob.7.l1169, Poui.7 I 170, Pob.C.l1182,
PcliP3 1297. PobP3 1323, Pob.DISQO0,
TL.B 41 13,T.D.5089,16.D.509 I,
Th.PD.5 IP0,1Th. D.5 I154, Th. D.5 15 6
16.D.515/.16.D.5158,16.D.5 60,
16.. 1I63,Th.D.5 1/2, P6.D.51I80,
Tocc.2339,Ti.D.2755,Tu.D.28 10,
To.1.295DWe.O.33 I13, We.P3.242,
We. P3 3606, We D.3640, We.P3.370
metabolism
N iB. I190, No.0. I1193, No.B. I1324,
No.0.138 1, Mo.O 1382. No.0 1387,
Nc...388, Nc..B.1 390,Mo.B.1393,

We.C.3580, We.C.3592

microsporidiosis
No.B. I114, No.0. 11I5, Pob.I 068,
16.1.4030, Th.A.4068, Th.1.4073,
16.0.421 2,16 0.4266, We.B. 3245
migration
No.7.1402, No.7. 1403, No.7. 1409,
No.7. 1484, No.D. I1690, Pub..I127,
Pob.7.I 1 4 7, Pub.C.I115 I, Pb.7.I1172,
Pob.7. (226, Pob.D. I1293, Pub.D. 141 5,
Publ..I14 I16.7.4648,16.D.5 136,
To.A 2027 Tu.7.26 74, Tu.7.2677,
Tu.D.244,T.D245, Tu.D.246, T.D.2/03,
T.D.2737 T.D.20904, PoD.2905,
Tu.D.2906, T.D.2908, We.7 3505,
We.ID.3/14
military
Mo.. 1483, Mo7.15 10, NoCISI I,
Ncc..151I9, No.7. I589, No.7.1I62 3,
No.31708, Mo.D.1717, No.D.1721.
No.1.I856, Mo.D.354, Pub.C.I1227,
16.7.45b3,16h..4682,lTh.7 471/,
16.7.4/23, Th.7.4847, Th.D.373,
T.7.244 I, T..26 I 6,T.C.26S9,
Tu.C.267 I,To D. 136
minorities
No.B. II6(3, No.7. 1403, No.7. 1509,
Mo.31I690, MoD. I799, No.D. I1899,
No. 1I900, Pub.B. 10)35, Pub.C. I1I70,
Pob.D.1290, Pub.D 1415, Pccb.D.14 16,
16.8.4 I30, 1h.B.4288,Th.7.203,
16.7.4549,16h.7.4665,16.7.46/2,
16.D.236,16h.D.4878, Th.D.4945, T.B.1/3,
Tu.B.2 I168, Tu.B.2362,Tc.7 2537,
Tu7.2550,Tu.7.2652,Tu.D. I 32,Tu.D.244,
To.D.245, TuD.246,T.D.2794,To.D.2863
To.D.2869, Tuc 72901I, Tc.D.2903.
T.D.2953, We.B.302, We.B.3162,
We.B.3 I6 6, We.7,3563, We.D.364/,
We.D.3664, We.D.3784, We.D,3785,
We.D.3848, We.D.483
mitogen response
No.1 1041, No.1.1372, citogen
response, We.1.3028,We..3054
MK-639
N o.1.106/7, Mo. B.170, MNo.0B. I74,
Th.B.4348,3o.B.212~4
model, computer
MO.A1052, MO.I 69,N o. 1400,
Mo.7.15/2, No.7.15/4, Moc.157,
No.7.1 578. No.D.342, Ti.0.4255.
Th.B.4333,Th..200.T6..200,Tlc.D.20,
Th.C.205, Tc..20 I9, T.1.2055, To..5/0.
We 7.2 10, We.7.35 16
model, mathematical
No.0. I1I69. No.7. 1573, No.7.1I574,
Mi 7.15 '6. No.7.1584, No.7 1585,
NoDC.1652, No.7.1/3 I, Nc.D.1914,
16.0.4 148.167C.121,.6.750,
Th.ID.363,16h.D.496/, T6.D.501I2.
Tc..2324,3ou.7.324,To.D 5/2,
We.7.344 I,We.7.3444, We D.362
modulation
MolA.1025, No.1.1035
molecular clones, HIV- I
No.A1021. No.0. 1137, Mo..I20
molluscum contagiosum
Mo.B. I28 1, T6,A.4(,

To.D 2784

morality
Mc.B.1 347/, NiD.1402. Ni.1544,
1.7(358.31 7,49/S. Icc 8.2)62,
We.P33647, We.D733(6
morphine
TI.B.4 1
mortality
Mc.B 1222, Nc.012/4,.c,1317,
Nc.O.1323, Mc 0 134o. No.B 13/I,
MoD.140,N D..1415.NMo.C.1428,
NoCD 1(46. N C 14 1,NMoc 151 3.
NoC 71541,. 7 1542,NMo S.14.
No.C.1545% N S.1c8, Mc (C I e8,
NoC.4' OciuTA 01 3, PoLB. 1061,
P iO.D. I144,. Dcli7 I343,Thc.8.300.
1L.B42 '0,11 834280,PThcO'(282,
16.0.4283,16.334291. 11.0.4298.
16.0.4306 Plc01143 18 16 7.22, 0
167C.221,16h.. 3 33,1h.D.4965, TcO.91,
ToB.2 18, ToOB.2139, Po.B2203,
T.0 231i0.To B.2 34o. 0uc. c4 4,
Tc..2i 4, p0 ( 3)7Q Iucc.2 i9,
lo.D.2S(2,Ic.( 432, Pci. 57 Ne 0 312,
We. B.315.Wc 133268,. e.03343,
WeD i4,I We.CD3425 WeDC.3441I
We. 7. (452, Wc..3462, We.D.3N75,
We.D 63
mouth, SEE oral
Mo.1026 PclA2O5l, We.A. 55.
We.1 7373, Viol 3098 hive.A13003
mRNA (messenger RNA)
No.A1 1c26, MN.AI 026,To..A.2056.
We I iS,We 1.3073, Ne A1 3098,
We..099
MT -2 cells
WeD.3338
MT -4 cells
No.1. 330,11..401 Qo IcCOi
mucins
No.0.9
mucous membranes
Mc.0.I1378,Th5 01261 IL C '13/8,
16.7.4(94. N. A. 141. We 1 285,
WA.13i0, e. A iO2 N'-.A1 9
multidrug-resistant tuberculosis
(MDRTB)
No.D 164/ N D..1650,NioC. 1656,
Plo..660,11 0.4306,11..071,
ThD.3 32,Tc Ic.2 354.icc 0 2 3 9. I 0.2 360.
Po.B 2361I,W' 8.3368
MuLV
Vel, '17
murine AIDS
Po.D.717 7/W, 1 0 0
mutation
No.A1. 0,N uAI I N 1.A380.
MolA.:l81.NcO 137,Ni0 B414,
Pib.l 001 1 h1 S( 6.058(328,
16.0.4 43, 161.343'1' Ih.B.4346,
160B4i5 1,Iic'\i 6,Tc..1'82IiO..3I15,
Wel 152, We I '15, We.0.3 S1
mycobacteria, other than tuberculosis
(including mycobacterium avium
complex, MAC)
No.0 18 8,.B119,NiO B 222.
No.i 43,.N 0B.21/, N.1280

Nc' 8.42/. N" 0 "124'

Qi
0
cU
Ci
cc
0
Ci
0i
a)
0
7)
cc
0
bc
491